SONN (Sonnet BioTherapeutics Holdings) Total Inventories: $0.00 Mil (As of Jun. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SONN Sonnet BioTherapeutics Holdings Inc SONN
28 GF Score
Price $1.26
View Full Analysis

What is Sonnet BioTherapeutics Holdings Total Inventories?

Sonnet BioTherapeutics Holdings SONN 28 Total Inventories is $0.00 Mil as of Jun. 2025. GuruFocus rates SONN with a GF Score™ of 28/100.

Sonnet BioTherapeutics Holdings's total inventories for the quarter that ended in Jun. 2025 was $0.00 Mil. Sonnet BioTherapeutics Holdings's average total inventories from the quarter that ended in Mar. 2025 to the quarter that ended in Jun. 2025 was $0.00 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Sonnet BioTherapeutics Holdings's Net-Net Working Capital per share for the quarter that ended in Jun. 2025 was $-1.43.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Sonnet BioTherapeutics Holdings  (NAS:SONN) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Sonnet BioTherapeutics Holdings's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2025 is

Net-Net Working Capital Per Share (Q: Jun. 2025 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(0.321+0.75 * 0+0.5 * 0-5.102
-0-0)/3.333
=-1.43

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Sonnet BioTherapeutics Holdings's Days Inventory for the three months ended in Jun. 2025 is calculated as:

Days Inventory=Average Total Inventories (Q: Jun. 2025 )/Cost of Goods Sold (Q: Jun. 2025 )*Days in Period
=0/0*365 / 4
=

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Sonnet BioTherapeutics Holdings's Inventory Turnover for the quarter that ended in Jun. 2025 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Jun. 2025 ) / Average Total Inventories (Q: Jun. 2025 )
=0 / 0
=N/A

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Sonnet BioTherapeutics Holdings's Inventory to Revenue for the quarter that ended in Jun. 2025 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Jun. 2025 ) / Revenue (Q: Jun. 2025 )
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Sonnet BioTherapeutics Holdings Total Inventories Related Terms

Sonnet BioTherapeutics Holdings Total Inventories Historical Data

* Premium members only.

The historical data trend for Sonnet BioTherapeutics Holdings's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sonnet BioTherapeutics Holdings Total Inventories Chart

Sonnet BioTherapeutics Holdings Annual Data
Trend Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Total Inventories
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Sonnet BioTherapeutics Holdings Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
SONN
28GF Score
Sonnet BioTherapeutics Holdings Inc SONN
Total Inventories is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sonnet BioTherapeutics Holdings Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Frequently Asked Questions Learn more about Total Inventories →
What does a Total Inventories of $0.00 Mil mean?
Sonnet BioTherapeutics Holdings (SONN) has a Total Inventories of $0.00 Mil as of Jun. 2025. The total amount of inventory as recorded on a company's balance sheet. View historical data for Sonnet BioTherapeutics Holdings and its competitors.
Is Sonnet BioTherapeutics Holdings' Total Inventories too high?
Sonnet BioTherapeutics Holdings' current Total Inventories is $0.00 Mil. Overall, Sonnet BioTherapeutics Holdings has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Sonnet BioTherapeutics Holdings' Total Inventories compare to CING and BOLD?
Sonnet BioTherapeutics Holdings' Total Inventories of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Biotechnology company?
A good Total Inventories depends on the Biotechnology industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Sonnet BioTherapeutics Holdings and its competitors. Sonnet BioTherapeutics Holdings's current Total Inventories is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sonnet BioTherapeutics Holdings stock overvalued right now?
Sonnet BioTherapeutics Holdings (SONN) has a current Total Inventories of $0.00 Mil. The current Total Inventories is $0.00 Mil. Sonnet BioTherapeutics Holdings' overall GF Score™ is 28/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Sonnet BioTherapeutics Holdings (SONN), the current Total Inventories is $0.00 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sonnet BioTherapeutics Holdings Business Description

Address 100 Overlook Center, Suite 102, Princeton, NJ, USA, 08540
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.
28GF Score

Get the complete analysis for SONN

Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.26
Price